Introduction
============

Chronic subdural hematomas (CSDHs) occur often in elderly persons and can occur with mild head trauma. CSDHs are commonly encountered in neurosurgical clinical practice, but the mechanism of onset and enlargement has not been fully elucidated, and much still remains unknown. With burr-hole irrigation as standard treatment, symptoms usually improve and can be cured, and outcomes are good, but postoperative recurrences are a common problem. The rate of postoperative recurrences varies among medical institutions, and the rates of 4.0--26.5% have been reported.^[@B1]--[@B14]^ Factors involved in CSDH recurrence include differences in surgical techniques, age, hematoma volume, computed tomography (CT) findings, and the types of drugs used, but these vary and still remain unclear.^[@B6],[@B13],[@B15]--[@B19]^ In addition to a variety of comorbidities in older patients, there are differences in these various factors, and this may account for differences in statistical analysis results. On the other hand, burr-hole irrigation, which is standard treatment in CSDH, is a relatively straightforward procedure that is done under local anesthesia. Therefore, if surgical techniques and postoperative management are uniform, with little variation among neurosurgeons, the prospective analysis of treatment outcomes would not be difficult.

Recently, artificial cerebrospinal fluid (ACF), with a composition close to normal cerebrospinal fluid (CSF), has been used for irrigation and perfusion in neurosurgery. This has been reported to reduce adverse events such as seizures and have a hemostatic effect on minor bleeding from the brain surface.^[@B20],[@B21]^ Normal saline (NS) has conventionally been used as an irrigation solution in burr-hole irrigation for CSDH, but the use of ACF may improve treatment effectiveness.

Therefore, a prospective study of 234 consecutive patients with CSDH who underwent burr-hole irrigation at our hospital was conducted. Various factors, including the type of irrigation solution (NS or ACF), were analyzed by univariate and multivariate analyses to investigate whether they contributed to CSDH recurrence rates.

Patients and Methods
====================

This study included 234 consecutive patients with CSDH who underwent burr-hole irrigation as the initial surgery by our Department of Neurosurgery at Higashihiroshima Medical Center (Higashihiroshima, Hiroshima Prefecture, Japan) between April 2008 and June 2015. Simultaneous bilateral surgery for a bilateral hematoma was regarded as one surgical operation. There were 157 men (67.1%) and 77 women (32.9%), with a mean age of 75.2 years (range: 21--96 years).

Surgery was performed as soon as possible after a confirmed diagnosis in all patients. Surgery was performed under local anesthesia, and a single burr hole was placed at the thickest point of the hematoma. The hematoma was aspirated as much as possible, the hematoma cavity was irrigated with NS through a silicone catheter, and then the burr hole was closed without inserting a drain. The scalp was closed in two layers. Residual air after closing was removed as much as possible, and this was replaced with NS. However, in June 2011, we started using ACF instead of NS as the irrigation solution. Patients received antibiotics by infusion for 3 days after surgery and were discharged from the hospital in about a week after surgery. They were followed-up for at least 3 months after discharge. Recurrence was defined by symptom exacerbation on the same side and within 3 months after initial surgery that again required surgery. Since the surgical procedure was uniform during this period, and all of the surgery was performed under the supervision of experienced neurosurgeons, it seems to be no significant difference by the operator. Before the surgery, written, informed consent was obtained from all patients and/or family members. The study protocol was approved by the ethics committee of our center.

Factors that were prospectively examined with regard to recurrence included age, sex, unilateral or bilateral surgery, CT findings (hematoma density, midline shift, septal wall, hematoma thickness), antiplatelet or anticoagulant drug use, past history (diabetes, ischemic heart disease, cerebrovascular disease, liver dysfunction, renal dysfunction), and irrigation solution (NS or ACF). Hematoma thickness was measured by drawing a line perpendicular to the longest diameter of the hematoma and the measuring thickness from the slice with maximum thickness.

In patients who were taking antiplatelet or anticoagulant drugs, surgery was usually performed under the same schedule, except that these drugs were discontinued before surgery. Hematoma density was classified into 4 categories as low, high, mixed (low and high), or isodense.

All analyses were performed using SPSS software (version 22.0, SPSS Inc.). In the recurrence and non-recurrence groups, patient characteristics were regarded as independent factors, and these were compared between groups using Pearson's chi-squared test. Multiple logistic regression analysis was also performed with recurrence as the dependent variable and patient characteristics as the explanatory variables. However, the number of patients with ischemic heart disease and renal dysfunction was disproportionate between the recurrence and non-recurrence groups. Therefore, these were excluded as factors from the multiple logistic regression model. The level of statistical significance was *P* \< 0.05.

Results
=======

Burr-hole irrigation was successfully performed in all 234 consecutive patients. There were no serious neurological complications or deaths. [Table 1](#T1){ref-type="table"} summarizes the patient characteristics. There were no significant differences in age, sex, hematoma right-left side difference, CT findings, the use of antiplatelet or anticoagulant drugs, or past history between the NS group and the ACF group ([Table 1](#T1){ref-type="table"}).

Among the 234 patients overall who underwent surgery, 36 (15.4%) had a recurrent CSDH within 3 months. Among the 101 patients in whom the irrigation solution was NS, 24 (23.8%) had a recurrence. In contrast, only 12 of 133 (9.0%) of patients in whom the irrigation solution was ACF had a recurrence. Prospective univariate analyses and multivariate analysis of the recurrence rates with regard to the irrigation solution showed that the use of ACF was a significant factor in reducing CSDH recurrence.

The 36 patients with recurrence included 25 men and 11 women, with a mean age of 75.6 years (range: 59--90 years). One patient had used an anticoagulant drug, eight had used antiplatelet drugs, seven had diabetes mellitus, two had cerebrovascular disease, one had ischemic heart disease, three had liver dysfunction, and one had renal dysfunction.

[Table 2](#T2){ref-type="table"} shows the results of univariate and multivariate analyses of factors in the 36 patients with recurrence and the 198 patients without recurrence. The results of univariate analysis, as described previously, showed a significant difference based on the type of irrigation solution. The recurrence rate was significantly lower in the ACF group than in the NS group (*P* = 0.003). None of the other factors, including age, sex, unilateral or bilateral surgery, CT findings (hematoma density, midline shift, septal wall, hematoma thickness), antiplatelet or anticoagulant drug use, and past history (diabetes mellitus, ischemic heart disease, cerebrovascular disease, liver dysfunction, renal dysfunction) had a significant effect on the recurrence rate. The results of multivariate analysis showed the risk of recurrence was reduced 3.14-fold in the ACF group compared to the NS group (odds ratio, 3.143; 95% confidence interval, 0.1504--0.6733; *P* = 0.0028). None of the other factors, including age, sex, unilateral or bilateral surgery, CT findings (hematoma density, midline shift, septal wall, hematoma thickness), antiplatelet or anticoagulant drug use, and past history (diabetes mellitus, cerebrovascular disease, liver dysfunction) was significantly different with respect to CSDH recurrence ([Table 2](#T2){ref-type="table"}).

Discussion
==========

CSDHs are relatively easy to treat by burr-hole irrigation under local anesthesia. However, the mechanisms by which CSDHs occur and enlarge, and the mechanisms by which CSDHs decrease and heal with irrigation, are not completely understood. With burr-hole irrigation, which is standard treatment for a CSDH, symptoms improve and can be cured, and outcomes are generally good. However, postoperative recurrences are a common problem.

Factors reportedly involved in recurrent CSDH include age, sex, hematoma thickness, use of antiplatelet and anticoagulant drugs, and past medical history.^[@B6],[@B13],[@B15]--[@B19])^ Recurrences related to surgical technique have also been frequently reported. However, few reports have compared recurrence rates with a focus on the type of irrigation solution used during surgery. Therefore, the present study focused on the composition of the ACF used as the irrigation solution during surgery and whether this would affect CSDH recurrence.

The rate of postoperative recurrent CSDH reported in the literature varies from 4.0% to 26.5%.^[@B1]--[@B14]^ The overall recurrence rate with our surgical procedure was 15.4%, which roughly corresponds with previously reported rates. However, the recurrence rate was 23.8% in patients in whom normal saline (NS) was used as the irrigation solution, but only 9.0% in those in whom ACF was used as the irrigation solution.

The present study was a prospective clinical study, and considering that most of the patients were elderly and had a variety of baseline characteristics, careful statistical analysis was necessary. On the other hand, surgical techniques and postoperative management in CSDH are relatively straightforward, so that there was not much room for variation in treatment. Therefore, we surmised that if statistical analysis were properly performed, results with a high level of evidence could be obtained. Various factors for recurrent CSDH were examined by both univariate and multivariate analyses. Both analyses showed similar results, namely, that using ACF as the irrigation solution significantly reduced the recurrence rate.

ACFs have recently been developed as solutions with a composition similar to normal CSF for the purpose of using a more physiologic irrigation solution during neurosurgical procedures. NS contains Na^+^ and Cl^−^ and has a pH of 6.3. In contrast, ACF, in addition to Na^+^ and Cl^−^, includes electrolytes such as Ca^2+^, K^+^, and HCO~3^−^~, as well as glucose, which are not present in NS. Moreover, ACF is adjusted to a more physiologic pH of 7.3 ([Table 3](#T3){ref-type="table"}).

The composition of CSF has been examined in basic research studies. In an *in vivo* study in a rat model with induced injury to the cerebral cortex, and in which NS and ACF were used to irrigate the brain surface, edema was less with ACF than with NS.

In another study, Nishimura et al.^[@B22]^ cultured astrocytes that were isolated from human fetal brains, and these were used to compare how irrigation and perfusion solutions affected brain cell function. They found that ACF had a significantly lower adverse effect on astrocyte function than did NS.

Another study compared histological changes in outer hematoma membranes after irrigation with NS or ACF in burr-hole irrigation of CSDHs.^[@B23]^ In outer hematoma membranes irrigated with NS, there was decreased extracellular matrix (ECM), cytoplasmic contraction, nuclear condensation, and eosinophilic infiltration. In contrast, in outer hematoma membranes irrigated with ACF, these findings were reduced, and chromatin structure was preserved.

These results demonstrated that in burr-hole irrigation in CSDHs damage of hematoma membranes is significantly less with exposure to ACF than NS. And therefore it is presumed that oozing from hematoma membranes is significantly less with exposure to ACF than NS.

This suggests that ACF is effective as an irrigation and perfusion solution in burr-hole surgery for CSDHs.

In another model of irrigation of bleeding on the mouse brain surface, ACF was more effective than NS for hemostasis, and the presumed mechanism involved the addition of Ca^2+^ and K^+^.^[@B4],[@B14]^ Therefore ACF acts on new blood vessels on the outer hematoma membrane, and may promote hemostasis of the outer hematoma membrane.

In a study comparing NS and ACF as a ventricular perfusate during endoneurosurgery, ACF was associated with a lower incidence of headache, fever, and nuchal rigidity. The presumed reason was that ACF caused less of an inflammatory reaction due to chemical irritation than NS.^[@B21],[@B24]^

In burr-hole irrigation in CSDH, for the reasons mentioned previously, the use of pH-adjusted ACF as an irrigation solution, which differs from mildly acidic NS, can also reduce damage of the hematoma membrane, thus decreasing CSDH recurrence rates. In addition, ACF acts on new blood vessels on the outer hematoma membrane, and by controlling vasoconstriction and blood clotting/fibrinolysis, ACF may promote hemostasis of the outer hematoma membrane.

Of particular note in the present study is the fact that a preoperative bleeding diathesis (liver dysfunction, renal dysfunction, the use of anticoagulant or antiplatelet drugs) did not significantly affect the CSDH recurrence rate. Previous reports have suggested that preoperative anticoagulant and antithrombotic therapy increases the risk of recurrence.^[@B25],[@B26]^ Moreover, with the increase in the elderly population, the number of patients with a bleeding diathesis (e.g., liver dysfunction, renal dysfunction) is increasing, and this bleeding diathesis has been reported as a factor in recurrence.^[@B16],[@B27]^ However, other studies have reported findings similar to the present study, namely, that the use of anticoagulant and antiplatelet drugs has no effect on CSDH recurrence rates.^[@B6],[@B13]^

Ko et al.^[@B16]^ reported that hematoma density was another important risk factor for CSDH recurrence, and that surgery should be delayed in high-density and mixed-density hematomas. Oishi et al.^[@B18]^ also reported a higher recurrence rate with high-density hematomas. On the other hand, Yoshii et al.^[@B19]^ reported a higher recurrence rate and that surgery should be delayed with low-density CT findings. Thus, there are differing opinions in the neurosurgical literature. The present statistical analysis showed that CT findings (hematoma density, hematoma thickness, midline shift, a septal wall, and unilateral or bilateral) had no significant effect on CSDH recurrence rates. Future studies with a larger number of patients may provide more accurate results.

Conclusions
===========

A prospective study of 234 consecutive patients who underwent initial burr-hole irrigation for CSDH was conducted, and factors related to recurrence were evaluated by univariate and multivariate analyses. Both sets of analyses showed similar results, namely, that ACF as an irrigation solution significantly reduced CSDH recurrence. None of the other factors examined had a significant effect on the recurrence rate.
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###### 

Baseline patient characteristics, clinical findings and the results of univariate analysis

                              All patients   ACF           NS            *P* value
  --------------------------- -------------- ------------- ------------- -----------
  Age                                                                    0.6778
    \< 75                     97 (41.5)      59 (44.4)     38 (37.6)     
    ≧ 75                      137 (58.5)     74 (55.6)     63 (62.4)     
  Sex                                                                    0.5756
    Male                      157 (67.1)     87 (65.4)     70 (69.3)     
    Female                    77 (32.9)      46 (34.6)     31 (30.7)     
  Operation side                                                         0.2361
    Right                     99 (42.3)      61 (45.9)     38 (37.6)     
    Left                      98 (41.9)      49 (36.8)     49 (48.5)     
    Both                      37 (15.8)      23 (17.3)     14 (13.9)     
  CT findings                                                            
    Density                                                              0.9096
      High                    24 (8.8)       14 (9.0)      10 (8.6)      
      Low                     41 (15.1)      24 (15.4)     17 (14.7)     
      Iso                     123 (45.2)     70 (44.9)     53 (45.7)     
      Mix                     84 (30.9)      48 (30.8)     36 (31.0)     
    Midline shift (mm)        7.53 ± 3.81    7.32 ± 3.53   7.82 ± 4.10   0.0627
    Septal wall                                                          0.4246
      Yes                     76 (27.9)      41 (26.3)     35 (30.2)     
      No                      196 (72.1)     115 (73.7)    81 (69.8)     
    Hematoma thickness (mm)   21.3 ± 8.21    21.5 ± 6.16   21.1 ± 6.09   0.6397
  Drug history                                                           
    Anticoagulant             19 (8.1)       15 (11.3)     4 (4.0)       0.0531
    Antiplatelet              34 (14.5)      18 (13.5)     16 (15.8)     0.7088
  Past history                                                           
    Diabetes mellitus         40 (17.1)      26 (19.5)     14 (13.9)     0.2949
    Ischemic heart disease    10 (4.3)       8 (6.0)       2 (2.0)       0.1939
    Cerebrovascular disease   16 (6.8)       10 (7.5)      6 (5.9)       0.7952
    Liver dysfunction         13 (5.6)       7 (5.3)       6 (5.9)       0.8227
    Renal dysfunction         4 (1.7)        3 (2.3)       1 (1.0)       0.6359

ACF: artificial cerebrospinal fluid, NS: normal saline, CT: computed tomography, values are means ± SD.

###### 

Results of univariate and multivariate analyses of chronic subdural hematoma recurrence

  Factor                               Univariate analysis   Multivariate analysis                                                                         
  ------------------------------------ --------------------- ----------------------- ------- ----------------------------------------- ------ ------------ ------------------------------------------
  Total                                198 (84.6)            36 (15.4)               15.4%                                                                 
  Age                                                                                        0.4704                                    0.99   0.96--1.02   0.5024
    \<75                               97 (49.0)             15 (41.7)               13.4%                                                                 
    ≧75                                101 (51.0)            21 (58.3)               17.2%                                                                 
  Sex                                                                                        0.8481                                    1.14   0.53--2.45   0.7443
    Male                               132 (66.7)            25 (69.4)               15.9%                                                                 
    Female                             66 (33.3)             11 (30.6)               14.3%                                                                 
  Operation side                                                                             0.6495                                    1.60   0.53--4.82   0.4043
    Right                              85 (42.9)             14 (38.9)               37.6%                                                                 
    Left                               80 (40.4)             18 (50.0)               18.4%                                                                 
    Both                               33 (16.7)             4 (11.1)                10.8%                                                                 
  CT findings                                                                                                                                              
    Density                                                                                  0.3776                                    1.20   0.57--2.51   0.6286
      High                             17 (7.4)              7 (16.7)                29.2%                                                                 
      Low                              33 (14.3)             8 (19.0)                19.5%                                                                 
      Iso                              107 (46.6)            16 (38.1)               13.0%                                                                 
      Mix                              73 (31.7)             11 (26.2)               13.1%                                                                 
    Midline shift (mm)                 6.68 ± 4.10           8.42 ± 4.24                     0.1052                                    0.94   0.86--1.03   0.1875
    Septal wall                                                                              0.9338                                    0.73   0.32--1.65   0.4498
      Yes                              65 (28.3)             11 (26.2)               14.5%                                                                 
      No                               165 (71.7)            31 (73.8)               15.8%                                                                 
    Hematoma thickness (mm)            21.1 ± 5.94           22.4 ± 6.13                     0.2291                                    0.95   0.90--1.01   0.1026
  Intraoperative irrigation solution                                                         0.003^[\*](#TFN3){ref-type="table-fn"}^   3.14   0.15--0.67   0.0028^[\*](#TFN3){ref-type="table-fn"}^
    NS                                 77 (38.9)             24 (66.7)               23.8%                                                                 
    ACF                                121 (61.1)            12 (33.3)               9.0%                                                                  
  Drug history                                                                                                                                             
    Anticoagulant                      18 (40.9)             1 (11.1)                        0.3219                                    0.29   0.04--2.21   0.2301
    Antiplatelet                       26 (59.1)             8 (88.9)                        0.1954                                    1.89   0.78--4.49   0.1597
  Past history                                                                                                                                             
    Diabetes mellitus                  29 (43.3)             7 (50.0)                        0.4561                                    1.48   0.62--3.55   0.3765
    Ischemic heart disease             8 (11.9)              2 (14.3)                        0.6543                                                        
    Cerebrovascular disease            16 (23.9)             1 (7.1)                         0.1417                                    1.40   0.28--6.86   0.6806
    Liver dysfunction                  10 (14.9)             3 (21.4)                        0.4283                                    1.71   0.45--6.54   0.4338
    Renal dysfunction                  4 (6.0)               1 (7.1)                         0.3897                                                        

ACF: artificial cerebrospinal fluid, NS: normal saline, CT: computed tomography, values are means ± SD, OR: odds ratio, CI: confidence interval,

*P* \< 0.05.

###### 

Composition of irrigation solutions and CSF

  Component            NS          ACF         Normal rat CSF   Normal human CSF
  -------------------- ----------- ----------- ---------------- ------------------
  Na^+^ (mEq/L)        154         145         150--152         145.5
  K^+^ (mEq/L)         --          2.8         3.5--6.2         2.8
  Mg^2+^ (mEq/L)       --          2.2         2.6--4.8         2.2
  Ca^2+^ (mEq/L)       --          2.3         3.0--5.0         2.3
  Cl^−^ (mEq/L)        154         129         132--136         111.9
  HCO~3^−^~ (mEq/L)    --          23.1        24--26           23.1
  P (mM/L)             --          1.1         n.a.             1.1
  Lactate^−^ (mEq/L)   --          --          n.a.             n.a.
  Glucose (g/L)        --          0.61        0.72--1.8        0.61
  Osmolality ratio     about 0.9   about 1     n.a.             about 1
  pH                   about 6.7   about 7.3   n.a.             7.307

NS: nomal saline, ACF: artifical cerebrospinal fluid, CSF: cerebrospinal fluid, n.a.: no data available.
